The treatment with hUC-MSC-EVs significantly reduced immune cell accumulation in the lung, especially neutrophil accumulation, reduced emphysema, reduced protein expression of p65, and downregulated DEG related to COPD. This evidence concerns the gene RELA and pulmonary emphysema.